“…Direct labeling is a simple procedure, but some drawbacks regarding lack of specificity and poor in vivo stability have limited its applicability, whereas indirect labeling with bifunctional chelating agents overcomes these difficulties in the preparation of the 99m Tc‐labeled peptides (Rezazadeh & Sadeghzadeh, 2019). Since adding a chelating moiety and a radionuclide may affect receptor‐binding affinity of the peptide, a spacer is used to keep the chelator away from the bioactive domain (Farahani, Maleki, & Sadeghzadeh, 2019). In 2004, Okarvi examined a N 3 S chelate system for labeling an analog of αM2 peptide with 99m Tc through a triproline (Pro 3 ) residue as a spacer for detection of breast carcinoma.…”